Crispr Therapeutics shares tumble after significant earnings miss
In a recent SEC filing, Coda Octopus Group , Inc. (NASDAQ:CODA), a profitable technology company with a strong balance sheet and impressive 37.5% one-year return, disclosed that Niels Sondergaard, a significant shareholder of the company, was awarded 10,000 shares of common stock. These shares were granted as compensation for services performed, as noted in the filing. Following this transaction, Sondergaard’s total direct ownership in the company increased to 2,251,581 shares. The shares were awarded at a price of $0, reflecting their nature as a service-related grant rather than a market purchase. According to InvestingPro analysis, CODA currently trades slightly above its Fair Value, with a healthy current ratio of 15.14 and strong profit margins of nearly 70%. For deeper insights into insider transactions and comprehensive financial analysis, including 5 additional ProTips, check out the detailed Pro Research Report available on InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.